Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong · Delayed Price · Currency is HKD 30.42
0.00 (0.00%)
At close: Feb 13, 2026
HKG:1501 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 189.9 | 191.91 | 156.46 | 131.71 | 142.96 | 121.35 |
Depreciation & Amortization | 80.83 | 78.54 | 46.63 | 36.41 | 29.69 | 21.65 |
Other Amortization | 1.33 | 1.33 | 0.92 | 0.67 | 0.52 | 0.31 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | 0.62 | 0.24 | 0.11 | 0.01 |
Asset Writedown & Restructuring Costs | 0.62 | 0.62 | - | - | 0.57 | -0.04 |
Loss (Gain) From Sale of Investments | 8.03 | 8.03 | -2.08 | -7.36 | -29.29 | -2.4 |
Loss (Gain) on Equity Investments | 0.4 | 0.4 | - | - | - | - |
Stock-Based Compensation | 6.79 | 6.79 | 6.49 | 3.11 | 1.11 | - |
Provision & Write-off of Bad Debts | -0.63 | -0.63 | 0.41 | 0.93 | - | - |
Other Operating Activities | -6.67 | -24.23 | -6.25 | -14.55 | -13.6 | -14.63 |
Change in Accounts Receivable | -16.48 | -16.48 | -44.22 | 7.73 | -74.94 | -22.6 |
Change in Inventory | -35.57 | -35.57 | 21.12 | -62.03 | -37.29 | -13.11 |
Change in Accounts Payable | 26 | 26 | 20.18 | 55.67 | 23.22 | -1.32 |
Change in Unearned Revenue | -11.17 | -11.17 | -22.13 | 27.95 | 29.7 | 6.49 |
Operating Cash Flow | 243.39 | 225.54 | 178.15 | 180.46 | 72.76 | 95.71 |
Operating Cash Flow Growth | 12.28% | 26.61% | -1.28% | 148.03% | -23.98% | 3.95% |
Capital Expenditures | -97.3 | -125.74 | -168.84 | -243.21 | -277.83 | -87.79 |
Sale of Property, Plant & Equipment | 3.84 | 3.72 | 0.78 | 0.87 | 1 | 0.64 |
Sale (Purchase) of Intangibles | -40 | -40 | -62.36 | -45 | -25.28 | -2.34 |
Investment in Securities | -86.38 | -34.42 | -64.28 | -35.38 | 19.5 | -96.72 |
Other Investing Activities | 10.09 | 9.13 | 10.89 | 6.52 | 14.53 | -35.66 |
Investing Cash Flow | -455.54 | -187.31 | -283.81 | -316.18 | -268.08 | -221.87 |
Short-Term Debt Issued | - | 228.02 | 88.34 | 32.66 | - | - |
Total Debt Issued | 580.6 | 228.02 | 88.34 | 32.66 | - | - |
Short-Term Debt Repaid | - | -80 | -42 | - | - | - |
Long-Term Debt Repaid | - | - | - | -0.19 | -0.32 | -0.4 |
Total Debt Repaid | -266.84 | -80 | -42 | -0.19 | -0.32 | -0.4 |
Net Debt Issued (Repaid) | 313.76 | 148.02 | 46.34 | 32.47 | -0.32 | -0.4 |
Issuance of Common Stock | - | 60 | 36 | 24 | - | - |
Repurchase of Common Stock | - | -18.92 | -21.26 | - | - | - |
Common Dividends Paid | - | -47.12 | -40.32 | -43.68 | -47.31 | -29.05 |
Other Financing Activities | 46.89 | -85.02 | -12.7 | -3.07 | 16.56 | 1.5 |
Financing Cash Flow | 360.65 | 56.97 | 8.06 | 9.72 | -31.07 | -27.95 |
Foreign Exchange Rate Adjustments | 1.08 | 3.08 | 3.01 | 3.72 | -3.19 | -12.55 |
Net Cash Flow | 149.57 | 98.29 | -94.6 | -122.28 | -229.58 | -166.65 |
Free Cash Flow | 146.08 | 99.8 | 9.31 | -62.75 | -205.07 | 7.92 |
Free Cash Flow Growth | 63.61% | 972.35% | - | - | - | -56.67% |
Free Cash Flow Margin | 15.87% | 11.71% | 1.24% | -10.71% | -44.13% | 2.21% |
Free Cash Flow Per Share | 0.85 | 0.58 | 0.05 | -0.37 | -1.23 | 0.05 |
Cash Interest Paid | 3.33 | 1.54 | 2.35 | 0.15 | 0.07 | 0.09 |
Cash Income Tax Paid | 36.26 | 38.73 | 19.59 | 12.66 | 15.02 | 18.96 |
Levered Free Cash Flow | 138.39 | -29.79 | -63.2 | -169.73 | -228.1 | -1.94 |
Unlevered Free Cash Flow | 141.09 | -28.27 | -61.2 | -169.22 | -227.7 | -1.89 |
Change in Working Capital | -37.22 | -37.22 | -25.06 | 29.31 | -59.32 | -30.54 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.